Home › All Companies › CPRX › Current Report

CATALYST PHARMACEUTICALS, INC. (CPRX) — Current Report

AI-Powered SEC Filing Analysis

← All CPRX filings
Latest Current Report Filed: 2026-05-11

Key Insights

  • The company issued Q1 2026 earnings results and business update on May 11, 2026, indicating continued operational reporting and transparency with shareholders.
  • The filing is minimal in substantive content, containing only a reference to an attached press release without detailed financial data or material events disclosed in the 8-K body itself.
  • Michael Kalb, EVP and CFO, signed the filing, confirming financial leadership continuity and proper authorization of disclosure documents.
  • As a NASDAQ-listed company with market cap indicator (NASDAQ Capital Market listing), the company maintains public company reporting obligations and investor communication protocols.
Sentiment: Neutral Significance: 3/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-05-11. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for CATALYST PHARMACEUTICALS, INC.

Quarterly Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.